REGiMMUNE's Series D Round

REGiMMUNE raised a round of funding on February 14, 2014.

REGiMMUNE is a biotechnology company focused on the discovery, development and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including alle…

Articles about REGiMMUNE's Series D Round: